da Cunha Santos, G., Shepherd, F.A., and Tsao, M.S., EGFR mutations and lung cancer, Annu. Rev. Pathol., 2011, vol. 6, pp. 49–69. https://doi.org/10.1146/annurev-pathol-011110-130206

Article  CAS  PubMed  Google Scholar 

Tan, C.S., Gilligan, D., and Pacey, S., Treatment approaches for EGFR-inhibitor-resistant patients with non-small-cell lung cancer, Lancet Oncol., 2015, vol. 16, pp. e447–e459. https://doi.org/10.1016/s1470-2045(15)00246-6

Article  CAS  PubMed  Google Scholar 

Singh, M. and Jadhav, H.R., Targeting non-small cell lung cancer with small-molecule EGFR tyrosine kinase inhibitors, Drug Discovery Today, 2018, vol. 23, pp. 745–753. https://doi.org/10.1016/j.drudis.2017.10.004

Article  CAS  PubMed  Google Scholar 

Wang, Z.F., Ren, S.X., Li, W., and Gao, G.H., Frequency of the acquired resistant mutation T790 M in non-small cell lung cancer patients with active exon 19Del and exon 21 L858R: A systematic review and meta-analysis, BMC Cancer, 2018, vol. 18, p. 148. https://doi.org/10.1186/s12885-018-4075-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liang, H., Pan, Z., Wang, W., Guo, C., Chen, D., et al., The alteration of T790M between 19 del and L858R in NSCLC in the course of EGFR-TKIs therapy: A literature-based pooled analysis, J. Thorac. Dis., 2018, vol. 10, pp. 2311–2320. https://doi.org/10.21037/jtd.2018.03.150

Article  PubMed  PubMed Central  Google Scholar 

Liang, H., Li, C., Zhao, Y., Zhao, S., Huang, J., et al., Concomitant mutations in EGFR 19Del/L858R mutation and their association with response to EGFR-TKIs in NSCLC patients, Cancer Manage. Res., 2020, vol. 12, pp. 8653–8662. https://doi.org/10.2147/cmar.S255967

Article  CAS  Google Scholar 

Ochi, N., Takeyama, M., Miyake, N., Fuchigami, M., Yamane, H., et al., The complexity of EGFR exon 19 deletion and L858R mutant cells as assessed by proteomics, transcriptomics, and metabolomics, Exp. Cell Res., 2023, vol. 424, p. 113503. https://doi.org/10.1016/j.yexcr.2023.113503

Article  CAS  PubMed  Google Scholar 

Comprehensive molecular portraits of human breast tumours, Nature, 2012, vol. 490, pp. 61–70. https://doi.org/10.1038/nature11412

Mermel, C.H., Schumacher, S.E., Hill, B., Meyerson, M.L., Beroukhim, R., et al., GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers, Genome Biol., 2011, vol. 12, p. R41. https://doi.org/10.1186/gb-2011-12-4-r41

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anders, S. and Huber, W., Differential expression analysis for sequence count data, Genome Biol., 2010, vol. 11, p. R106. https://doi.org/10.1186/gb-2010-11-10-r106

Article  CAS  PubMed  PubMed Central  Google Scholar 

Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., et al., Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. U. S. A., 2005, vol. 102, pp. 15545–15550. https://doi.org/10.1073/pnas.0506580102

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li, T., Fu, J., Zeng, Z., Cohen, D., Li, J., et al., TI-MER2.0 for analysis of tumor-infiltrating immune cells, Nucleic Acids Res., 2020, vol. 48, pp. W509–W514. https://doi.org/10.1093/nar/gkaa407

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hernández, J., Bechara, E., Schlesinger, D., Delgado, J., Serrano, L., et al., Tumor suppressor properties of the splicing regulatory factor RBM10, RNA Biol., 2016, vol. 13, pp. 466–472. https://doi.org/10.1080/15476286.2016.1144004

Article  PubMed  PubMed Central  Google Scholar 

Wang, K., Bacon, M.L., Tessier, J.J., Rintala-Maki, N.D., Tang, V., et al., RBM10 modulates apoptosis and influences TNF-α gene expression, J. Cell Death, 2012, vol. 5, pp. 1–19. https://doi.org/10.4137/jcd.S9073

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao, J., Sun, Y., Huang, Y., Song, F., Huang, Z., et al., Functional analysis reveals that RBM10 mutations contribute to lung adenocarcinoma pathogenesis by deregulating splicing, Sci. Rep., 2017, vol. 7, p. 40488. https://doi.org/10.1038/srep40488

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeng, Q., Sun, S., Li, Y., Li, X., Li, Z., et al., Identification of therapeutic targets and prognostic biomarkers among CXC chemokines in the renal cell carcinoma microenvironment, Front. Oncol., 2019, vol. 9, p. 1555. https://doi.org/10.3389/fonc.2019.01555

Article  PubMed  Google Scholar 

Shi, S., Ye, S., Mao, J., Ru, Y., Lu, Y., et al., CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer, Autoimmunity, 2020, vol. 53, pp. 210–217. https://doi.org/10.1080/08916934.2020.1735371

Article  CAS  PubMed  Google Scholar 

Li, T., Pang, X., Wang, J., Wang, S., Guo, Y., et al., Exploration of the tumor-suppressive immune microenvironment by integrated analysis in EGFR-mutant lung adenocarcinoma, Front. Oncol., 2021, vol. 11, p. 591922. https://doi.org/10.3389/fonc.2021.591922

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, C., Liang, H., Lin, C., Li, F., Xie, G., et al., Molecular subtyping and prognostic assessment based on tumor mutation burden in patients with lung adenocarcinomas, Int. J. Mol. Sci., 2019, vol. 20, p. 4251. https://doi.org/10.3390/ijms20174251

Article  CAS  PubMed  PubMed Central  Google Scholar 

Spiliopoulou, P., Yang, S.Y.C., Bruce, J.P., Wang, B.X., Berman, H.K., et al., All is not lost: Learning from 9p21 loss in cancer, Trends Immunol., 2022, vol. 43, pp. 379–390. https://doi.org/10.1016/j.it.2022.03.003

Article  CAS  PubMed  Google Scholar 

Eichenauer, T., Simmendinger, L., Kluth, M., Chirico, V., Luebke, A.M., et al., Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancer, Urol. Oncol., 2020, vol. 38, pp. 605.e601–605.e608. https://doi.org/10.1016/j.urolonc.2020.02.022

Article  CAS  Google Scholar 

Alentorn, A., Dehais, C., Ducray, F., Carpentier, C., Mokhtari, K., et al., Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas, Neurology, 2015, vol. 85, pp. 1325–1331. https://doi.org/10.1212/wnl.0000000000002014

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ghobadi, N., Mehramiz, M., ShahidSales, S., Rezaei Brojerdi, A., Anvari, K., et al., A genetic variant in C-DKN2A/2B locus was associated with poor prognosis in patients with esophageal squamous cell carcinoma, J. Cell. Physiol., 2019, vol. 234, pp. 5070–5076. https://doi.org/10.1002/jcp.27310

Article  CAS  PubMed  Google Scholar 

Xia, Y., Liu, Y., Yang, C., Simeone, D.M., Sun, T.T., et al., Dominant role of CDKN2B/p15INK4B of 9p21.3 tumor suppressor hub in inhibition of cell-cycle and glycolysis, Nat. Commun., 2021, vol. 12, p. 2047. https://doi.org/10.1038/s41467-021-22327-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hustinx, S.R., Leoni, L.M., Yeo, C.J., Brown, P.N., Goggins, M., et al., Concordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia: Evidence of homozygous deletion in a noninvasive precursor lesion, Mod. Pathol., 2005, vol. 18, pp. 959–963. https://doi.org/10.1038/modpathol.3800377

Article  CAS  PubMed  Google Scholar